SomnoMed Ltd (OTCPK:SOMNF)
$ 0.1653 0 (0%) Market Cap: 62.07 Mil Enterprise Value: 56.16 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 48/100

Half Year 2022 Somnomed Ltd Earnings Call Transcript

Feb 22, 2022 / 12:00AM GMT
Release Date Price: $1.43
Operator

Thank you for standing by, and welcome to the SomnoMed 2022 Half Year Results Call. (Operator Instructions)

I would like to now hand over the conference to Neil Verdal-Austin, CEO. Please go ahead, Neil.

Neil Verdal;Austin
SomnoMed Limited - Global CEO, MD & Director

Thank you, Lisa. Well, good morning, ladies and gentlemen. And as mentioned, my name is Neil Verdal-Austin, and I'm the CEO of SomnoMed Limited. Thank you for joining us for this audio webcast where we present our half year '22 results and elaborate further on the new technology recently announced.

The disclaimer and agenda slides are self-explanatory, so let's start with Slide 5, the half year financial highlights. We are extremely pleased with the revenue growth seen in the North American region, while in Europe, this growth was softened by the various COVID restrictions, limiting our access to physicians and hospitals, while patients also postponed their dental appointments due to the COVID pandemic.

In APAC, we experienced the same due to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot